AP
BIO icon

Advisor Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Advisor Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$621K Buy
1,254
+114
+10% +$59.4K 0.04% 415
2022
Q1 		$642K Sell
1,140
-10
-0.9% -$6.03K 0.04% 437
2021
Q4 		$869K Buy
1,150
+135
+13% +$101K 0.05% 345
2021
Q3 		$757K Sell
1,015
-48
-5% -$36K 0.05% 363
2021
Q2 		$685K Sell
1,063
-67
-6% -$40.8K 0.05% 403
2021
Q1 		$645K Buy
1,130
+53
+5% +$31.4K 0.05% 401
2020
Q4 		$628K Buy
1,077
+68
+7% +$38.7K 0.05% 380
2020
Q3 		$520K Buy
1,009
+50
+5% +$25.3K 0.04% 381
2020
Q2 		$433K Buy
959
+27
+3% +$11.9K 0.04% 402
2020
Q1 		$326K Buy
932
+94
+11% +$34.6K 0.04% 414
2019
Q4 		$315K Buy
838
+1
+0.1% +$353 0.03% 484
2019
Q3 		$279K Buy
837
+7
+0.8% +$2.28K 0.03% 495
2019
Q2 		$259K Sell
830
-15
-2% -$4.49K 0.03% 506
2019
Q1 		$258K Sell
845
-27
-3% -$7.29K 0.03% 493
2018
Q4 		$202K Buy
872
+7
+0.8% +$1.88K 0.03% 549
2018
Q3 		$271K Sell
865
-4
-0.5% -$1.24K 0.04% 490
2018
Q2 		$251K Buy
869
+14
+2% +$3.87K 0.04% 473
2018
Q1 		$214K Sell
855
-71
-8% -$18.1K 0.04% 509
2017
Q4 		$236K Buy
926
+2
+0.2% +$485 0.04% 480
2017
Q3 		$205K Sell
924
-1
-0.1% -$225 0.04% 458
2017
Q2 		$209K Buy
+925
New +$202K 0.05% 431

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Advisor Partners's BIO Position: Q2 2022 in Review

Advisor Partners increased its Bio-Rad Laboratories Class A (BIO) stake by 10% in Q2 2022, buying an estimated $59.4K and bringing the position to 1,254 shares worth $621K. The position accounts for 0.04% of the portfolio, ranked #415.

Advisor Partners first reported a position in BIO in Q2 2017 and has held it in 21 quarters since. The position peaked at $869K in Q4 2021. 500 funds tracked by Wall St. Rank hold BIO as of Q2 2022.

  • Advisor Partners held 1,254 shares of Bio-Rad Laboratories Class A worth $621K as of Q2 2022.
  • Advisor Partners bought 114 Bio-Rad Laboratories Class A shares in Q2 2022, an estimated $59.4K.
  • Bio-Rad Laboratories Class A made up 0.04% of Advisor Partners's portfolio in Q2 2022, its #415 holding.
  • Advisor Partners first reported a position in Bio-Rad Laboratories Class A in Q2 2017 and has held it in 21 quarters since.
  • Advisor Partners's Bio-Rad Laboratories Class A position peaked at $869K in Q4 2021.
  • 500 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.